Table 3 Baseline characteristics of efficacy measurements of patients receiving TSC and placebo
Characteristics | TSC (N = 750) | Placebo (N = 250) | P values |
|---|---|---|---|
Times of headache attacks, mean ± SD, no. | 4.01 ± 1.14 | 3.93 ± 1.15 | 0.2896 |
Headache duration, mean ± SD, h | 8.26 ± 7.44 | 8.66 ± 8.75 | 0.4915 |
VAS of headache, mean ± SD | 5.10 ± 1.41 | 5.00 ± 1.35 | 0.2940 |
Days of acute analgesic use, mean ± SD, d | 2.55 ± 1.81 | 2.49 ± 1.85 | 0.6744 |
Nausea, mean ± SD, no. | 3.59 ± 1.53 | 3.58 ± 1.49 | 0.6703 |
Vomiting, mean ± SD, no. | 1.78 ± 1.95 | 1.76 ± 1.92 | 0.8831 |
Photophobia, mean ± SD, no. | 2.02 ± 1.82 | 2.09 ± 1.84 | 0.6059 |
Phonophobia, mean ± SD, no. | 1.40 ± 1.71 | 1.28 ± 1.62 | 0.4308 |